Healthcare resource utilization and costs of care in the United States for patients with non-alcoholic steatohepatitis.
Elliot B TapperMachaon BonafedeJesse FishmanStephen DodgeKeith MillerNi ZengDave LewandowskiAlina BogdanovPublished in: Journal of medical economics (2023)
A higher FIB-4 was associated with increased healthcare costs and risk of hospitalization in adults with NASH; however, even patients with FIB-4 ≤ 0.95 presented a significant burden.